Three-dimensional models of HDL apoA-I: Implications for its assembly and function

Journal of Lipid Research

Volumn 49, Issue 9, 2008, Pages 1875-1883

  Thomas, Michael J ^a   Bhat, Shaila ^a   Sorci Thomas, Mary ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein A I; Chemical crosslinking; Cholesterol; Exchange; Hydrogen deuterium; Mass spectrometry; Molecular dynamic modeling

Indexed keywords

APOLIPOPROTEIN A1; CHYMOTRYPSIN; HIGH DENSITY LIPOPROTEIN; LIPID; METHIONINE; RECOMBINANT PROTEIN; CHOLESTEROL;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DEUTERIUM HYDROGEN EXCHANGE; FLUORESCENCE RESONANCE ENERGY TRANSFER; LIPID DEGRADATION; MASS SPECTROMETRY; MOLECULAR DYNAMICS; MOLECULAR MODEL; OXIDATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS; X RAY DIFFRACTION; AUDIOVISUAL EQUIPMENT; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

APOLIPOPROTEIN A-I; CHOLESTEROL; COMPUTER SIMULATION; DEUTERIUM EXCHANGE MEASUREMENT; METHIONINE; MODELS, MOLECULAR; MODELS, STRUCTURAL; OXIDATION-REDUCTION; PROTEIN CONFORMATION; RECOMBINANT PROTEINS;

EID: 53149092105     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800010-JLR200     Document Type: Review

References (96)

1. Zannis, V. I., A. Chroni, and M. Krieger. 2006. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J. Mol. Med. 84: 276-294.
2. Yancey, P. G., A. E. Bortnick, G. Kellner-Weibel, M. de la Llera-Moya, M. C. Phillips, and G. H. Rothblat. 2003. Importance of different pathways of cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23: 712-719.
3. Rader, D. J. 2006. Molecular regulation of HDL metabolism and function: implications for novel therapies. J. Clin. Invest. 116: 3090-3100.
4. Boden, W. E. 2000. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am. J. Cardiol. 86: 19L-22L.
5. Luoma, P. V. 1997. Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity. Pharmacol. Toxicol. 81: 57-64.
6. Kim, K. D., H. Y. Lim, H. G. Lee, D. Y. Yoon, Y. K. Choe, I. Choi, S. G. Paik, Y. S. Kim, Y. Yang, and J. S. Lim. 2005. Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation. Biochem. Biophys. Res. Commun. 338: 1126-1136.
7. Norata, G. D., P. Marchesi, A. Pirillo, P. Uboldi, G. Chiesa, V. Maina, C. Garlanda, A. Mantovani, and A. L. Catapano. 2008. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28: 925-931.
8. Gotsman, I., R. Gupta, and A. H. Lichtman. 2007. The influence of the regulatory T lymphocytes on atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27: 2493-2495.
9. Hansson, G. K., and P. Libby. 2006. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6: 508-519.
10. Binder, C. J., M. K. Chang, P. X. Shaw, Y. I. Miller, K. Hartvigsen, A. Dewan, and J. L. Witztum. 2002. Innate and acquired immunity in atherogenesis. Nat. Med. 8: 1218-1226.
11. Barter, P., A. M. Gotto, J. C. LaRosa, J. Maroni, M. Szarek, S. M. Grundy, J. J. Kastelein, V. Bittner, and J. C. Fruchart. 2007. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N. Engl. J. Med. 357: 1301-1310.
12. Timmins, J. M., J. Y. Lee, E. Boudyguina, K. D. Kluckman, L. R. Brunham, A. Mulya, A. K. Gebre, J. M. Coutinho, P. L. Colvin, T. L. Smith, et al. 2005. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J. Clin. Invest. 115: 1333-1342.
13. Oram, J. F., and J. W. Heinecke. 2005. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 85: 1343-1372.
14. Brunham, L. R., R. R. Singaraja, and M. R. Hayden. 2006. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Annu. Rev. Nutr. 26: 105-129.
15. Krimbou, L., H. Hajj Hassan, S. Blain, S. Rashid, M. Denis, M. Marcil, and J. Genest. 2005. Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines. J. Lipid Res. 46: 1668-1677.
16. Doung, P. T., H. L. Collins, M. Nickel, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 2006. Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I. J. Lipid Res. 47: 832-843.
17. Mulya, A., J. Y. Lee, A. K. Gebre, M. J. Thomas, P. L. Colvin, and J. S. Parks. 2007. Minimal lipidation of prebeta HDL by ABCA1 results in reduced ability to interact with ABCA1. Arterioscler. Thromb. Vasc. Biol. 8: 1828-1836.
18. Doung, P. T., G. L. Weibel, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 2008. Characterization and properties of preβ-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I. J. Lipid Res. 49: 1006-1014.
19. Curtiss, L. K., D. T. Valenta, N. J. Hime, and K. A. Rye. 2006. What is so special about apolipoprotein AI in reverse cholesterol transport? Arterioscler. Thromb. Vasc. Biol. 26: 12-19.
20. Sorci-Thomas, M. G., and M. J. Thomas. 2002. The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc. Med. 12: 121-128.
21. von Eckardstein, A. 2006. Differential diagnosis of familial high density lipoprotein deficiency syndromes. Atherosclerosis. 186: 231-239.
22. Koukos, G., A. Chroni, A. Duka, D. Kardassis, and V. I. Zannis. 2007. LCAT can rescue the abnormal phenotype produced by the natural apoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN. Biochemistry. 46: 10713-10721.
23. McPherson, P. A., I. S. Young, and J. McEneny. 2007. A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation. Free Radic. Biol. Med. 43: 1484-1493.
24. Asztalos, B. F., E. J. Schaefer, K. V. Horvath, S. Yamashita, M. Miller, G. Franceschini, and L. Calabresi. 2007. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J. Lipid Res. 48: 592-599.
25. Gursky, O., and D. Atkinson. 1996. Thermal unfolding of human high-density apolipoprotein A-1: implications for a lipid-free molten globular state. Proc. Natl. Acad. Sci. USA. 93: 2991-2995.
26. Segrest, J. P., M. K. Jones, H. De Loof, C. G. Brouillette, Y. V. Venkatachalapathi, and G. M. Anantharamaiah. 1992. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33: 141-166.
27. Chan, L. 1989. The apolipoprotein multigene family: structure, expression, evolution, and molecular genetics. Klin. Wochenschr. 67: 225-237.
28. Borhani, D. W., D. P. Rogers, J. A. Engler, and C. G. Brouillette. 1997. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94: 12291-12296.
29. Brouillette, C. G., G. M. Anantharamaiah, J. A. Engler, and D. W. Borhani. 2001. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim. Biophys. Acta. 1531: 4-46.
30. Brouillette, C. G., W. J. Dong, Z. W. Yang, M. J. Ray, I. I. Protasevich, H. C. Cheung, and J. A. Engler. 2005. Forster resonance energy transfer measurements are consistent with a helical bundle model for lipid-free apolipoprotein A-I. Biochemistry. 44: 16413-16425.
31. Yokoyama, S., S. Tajima, and A. Yamamoto. 1982. The process of dissolving apolipoprotein A-I in an aqueous buffer. J. Biochem. 91: 1267-1272.
32. Segrest, J. P., D. W. Garber, C. G. Brouillette, S. C. Harvey, and G. M. Anantharamaiah. 1994. The amphipathic a-helix: a multifunctional structural motif in plasma apolipoproteins. Adv. Protein Chem. 45: 303-369.
33. Segrest, J. P., R. L. Jackson, J. D. Morrisett, and A. M. Gotto. 1974. A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett. 38: 247-258.
34. Mishra, V. K., M. N. Palgunachari, J. P. Segrest, and G. M. Anantharamaiah. 1994. Interactions of synthetic peptide analogs of the class A amphipathic helix with lipids. Evidence for the snorkel hypothesis. J. Biol. Chem. 269: 7185-7191.
35. MacRaild, C. A., G. J. Howlett, and P. R. Gooley. 2004. The structure and interactions of human apolipoprotein C-II in dodecyl phosphocholine. Biochemistry. 43: 8084-8093.
36. Rogers, D. P., L. M. Roberts, J. Lebowitz, J. A. Engler, and C. G. Brouillette. 1998. Structural analysis of apolipoprotein A-I: effects of amino- and carboxy-terminal deletions on the lipid-free structure. Biochemistry. 37: 945-955.
37. Martin, D. D., M. S. Budamagunta, R. O. Ryan, J. C. Voss, and M. N. Oda. 2006. Apolipoprotein A-I assumes a "looped belt" conformation on reconstituted high density lipoprotein. J. Biol. Chem. 281: 20418-20426.
38. Barbeau, D. L., A. Jonas, T. Teng, and A. M. Scanu. 1979. Asymmetry of apolipoprotein A-I in solution as assessed from ultracentrifugal, viscometric, and fluorescence polarization studies. Biochemistry. 18: 362-369.
39. Rogers, D. P., L. M. Roberts, J. Lebowitz, G. Datta, G. M. Anantharamaiah, J. A. Engler, and C. G. Brouillette. 1998. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry. 37: 11714-11725.
40. Borhani, D. W., J. A. Engler, and C. G. Brouillette. 1999. Crystallization of truncated human apolipoprotein A-I in a novel conformation. Acta Crystallogr. D Biol. Crystallogr. 55: 1578-1583.
41. Wilson, C., M. R. Wardell, K. H. Weisgraber, R. W. Mahley, and D. A. Agard. 1991. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science. 252: 1817-1822.
42. Ajees, A. A., G. M. Anantharamaiah, V. K. Mishra, M. M. Hussain, and H. M. Murthy. 2006. Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proc. Natl. Acad. Sci. USA. 103: 2126-2131.
43. Tanaka, M., M. Koyama, P. Dhanasekaran, D. Nguyen, M. Nickel, S. Lund-Katz, H. Saito, and M. C. Phillips. 2008. Influence of tertiary structure domain properties on the functionality of apolipoprotein A-I. Biochemistry. 47: 2172-2180.
44. Saito, H., P. Dhanasekaran, D. Nguyen, P. Holvoet, S. Lund-Katz, and M. C. Phillips. 2003. Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model. J. Biol. Chem. 278: 23227-23232.
45. Ren, X., L. Zhao, A. Sivashanmugam, Y. Miao, L. Korando, Z. Yang, C. A. Reardon, G. S. Getz, C. G. Brouillette, W. G. Jerome, et al. 2005. Engineering mouse apolipoprotein A-I into a monomeric, active protein useful for structural determination. Biochemistry. 44: 14907-14919.
46. Davidson, W. S., K. Arnvig-McGuire, A. Kennedy, J. Kosman, T. L. Hazlett, and A. Jonas. 1999. Structural organization of the N-terminal domain of apolipoprotein A-I: studies of tryptophan mutants. Biochemistry. 38: 14387-14395.
47. Silva, R. A., G. M. Hilliard, J. Fang, S. Macha, and W. S. Davidson. 2005. A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading. Biochemistry. 44: 2759-2769.
48. Davidson, W. S., T. Hazlett, W. W. Mantulin, and A. Jonas. 1996. The role of apolipoprotein AI domains in lipid binding. Proc. Natl. Acad. Sci. USA. 93: 13605-13610.
49. Lagerstedt, J. O., M. S. Budamagunta, M. N. Oda, and J. C. Voss. 2007. EPR spectroscopy of site-directed spin labels reveals the structural heterogeneity in the N-terminal domain of apo-AI in solution. J. Biol. Chem. 282: 9143-9149.
50. Davidson, W. S., and T. B. Thompson. 2007. The structure of apolipoprotein A-I in high density lipoproteins. J. Biol. Chem. 282: 9143-9149.
51. Leroy, A., and A. Jonas. 1994. Native-like structure and self-association behavior of apolipoprotein A-I in a water/n-propanol solution. Biochim. Biophys. Acta. 1212: 285-294.
52. Saito, H., S. Lund-Katz, and M. C. Phillips. 2004. Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Prog. Lipid Res. 43: 350-380.
53. Rogers, D. P., C. G. Brouillette, J. A. Engler, S. W. Tendian, L. Roberts, V. K. Mishra, G. M. Anantharamaiah, S. Lund-Katz, M. C. Phillips, and M. J. Ray. 1997. Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation. Biochemistry. 36: 288-300.
54. Zhu, H. L., and D. Atkinson. 2004. Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I. Biochemistry. 43: 13156-13164.
55. Lagerstedt, J. O., G. Cavigiolio, L. M. Roberts, H. S. Hong, L. W. Jin, P. G. Fitzgerald, M. N. Oda, and J. C. Voss. 2007. Mapping the structural transition in an amyloidogenic apolipoprotein A-I. Biochemistry. 46: 9693-9699.
56. Zhu, H. L., and D. Atkinson. 2007. Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I. Biochemistry. 46: 1624-1634.
57. Laccotripe, M., S. C. Makrides, A. Jonas, and V. I. Zannis. 1997. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. J. Biol. Chem. 272: 17511-17522.
58. Oda, M. N., T. M. Forte, R. O. Ryan, and J. C. Voss. 2003. The C-terminal domain of apolipoprotein A-I contains a lipid-sensitive conformational trigger. Nat. Struct. Biol. 10: 455-460.
59. Palgunachari, M. N., V. K. Mishra, S. Lund-Katz, M. C. Phillips, S. O. Adeyeye, S. Alluri, G. M. Anantharamaiah, and J. P. Segrest. 1996. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly. Arterioscler. Thromb. Vasc. Biol. 16: 328-338.
60. Beckstead, J. A., B. L. Block, J. K. Bielicki, C. M. Kay, M. N. Oda, and R. O. Ryan. 2005. Combined N- and C-terminal truncation of human apolipoprotein A-I yields a folded, functional central domain. Biochemistry. 44: 4591-4599.
61. Segrest, J. P., M. K. Jones, A. E. Klon, C. J. Sheldahl, M. Hellinger, H. De Loof, and S. C. Harvey. 1999. A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J. Biol. Chem. 274: 31755-31758.
62. Koppaka, V., L. Silvestro, J. A. Engler, C. G. Brouillette, and P. H. Axelsen. 1999. The structure of human lipoprotein A-I. Evidence for the "belt" model. J. Biol. Chem. 274: 14541-14544.
63. Mishra, V. K., G. M. Anantharamaiah, J. P. Segrest, M. N. Palgunachari, M. Chaddha, S. W. Sham, and N. R. Krishna. 2006. Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide. lipid discoidal complexes. J. Biol. Chem. 281: 6511-6519.
64. Tricerri, M. A., A. K. Behling Agree, S. A. Sanchez, J. Bronski, and A. Jonas. 2001. Arrangement of apolipoprotein A-I in reconstituted high-density lipoprotein disks: an alternative model based on fluorescence resonance energy transfer experiments. Biochemistry. 40: 5065-5074.
65. Li, H. H., D. S. Lyles, M. J. Thomas, W. Pan, and M. G. Sorci-Thomas. 2000. Structural determination of lipid-bound apoA-I using fluorescence resonance energy transfer. J. Biol. Chem. 275: 37048-37054.
66. Li, H. H., M. J. Thomas, W. Pan, E. Alexander, M. Samuel, and M. G. Sorci-Thomas. 2001. Preparation and incorporation of probe-labeled apoA-I for fluorescence resonance energy transfer studies of rHDL. J. Lipid Res. 42: 2084-2091.
67. Li, H. H., D. S. Lyles, W. Pan, E. Alexander, M. J. Thomas, and M. G. Sorci-Thomas. 2002. ApoA-I structure on discs and spheres. Variable helix registry and conformational states. J. Biol. Chem. 42: 39093-39101.
68. Maiorano, J. N., R. J. Jandacek, E. M. Horace, and W. S. Davidson. 2004. Identification and structural ramifications of a hinge domainin apolipoprotein A-I discoidal high-density lipoproteins of different size. Biochemistry. 43: 11717-11726.
69. Corsico, B., J. D. Toledo, and H. A. Garda. 2001. Evidence for a central apolipoprotein A-I domain loosely bound to lipids in discoidal lipoproteins that is capable of penetrating the bilayer of phospholipid vesicles. J. Biol. Chem. 276: 16978-16985.
70. Davidson,W. S., and G. M. Hilliard. 2003. The spatial organization of apolipoprotein A-I on the edge of discoidal high density lipoprotein particles: a mass spectrometry study. J. Biol. Chem. 278: 27199-27207.
71. Silva, R. A., G. M. Hilliard, L. Li, J. P. Segrest, and W. S. Davidson. 2005. A mass spectrometric determination of the conformation of dimeric apolipoprotein A-I in discoidal high density lipoproteins. Biochemistry. 44: 8600-8607.
72. Davidson, W. S., and R. A. Silva. 2005. Apolipoprotein structural organization in high density lipoproteins: belts, bundles, hinges and hairpins. Curr. Opin. Lipidol. 16: 295-300.
73. Bhat, S., M. G. Sorci-Thomas, E. T. Alexander, M. P. Samuel, and M. J. Thomas. 2005. Intermolecular contact between globular Nterminal fold and C-terminal domain of apoA-I stabilizes its lipidbound conformation: studies employing chemical cross-linking and mass spectrometry. J. Biol. Chem. 280: 33015-33025.
74. Bhat, S., M. G. Sorci-Thomas, R. Tuladhar, M. P. Samuel, and M. J. Thomas. 2007. Conformational adaptation of apolipoprotein A-I to discretely sized phospholipid complexes. Biochemistry. 46: 7811-7821.
75. Wu, Z., M. A. Wagner, L. Zheng, J. S. Parks, J. M. Shy III, J. D. Smith, V. Gogonea, and S. L. Hazen. 2008. The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction [erratum]. Nat. Struct. Mol. Biol. 15: 330, 651.
76. Shih, A. Y., S. G. Sligar, and K. Schulten. 2008. Molecular models need to be tested: the case of a solar flares discoidal HDL model. Biophys. J. 94: L87-L89.
77. Sorci-Thomas, M. G., M. W. Kearns, and J. P. Lee. 1993. Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships. J. Biol. Chem. 268: 21403-21409.
78. Sorci-Thomas, M. G., M. J. Thomas, L. K. Curtiss, and M. Landrum. 2000. Single repeat deletion in apoA-I blocks cholesterol esterification and results in rapid catabolism of D6 and wild-type apoA-I in transgenic mice. J. Biol. Chem. 275: 12156-12163.
79. Roosbeek, S., B. Vanloo, N. Duverger, H. Caster, J. Breyne, I. De Beun, H. Patel, J. Vandekerckhove, C. Shoulders, M. Rosseneu, et al. 2001. Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase. J. Lipid Res. 42: 31-40.
80. Alexander, E. T., S. Bhat, M. J. Thomas, R. B. Weinberg, V. R. Cook, M. S. Bharadwaj, and M. G. Sorci-Thomas. 2005. Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithin:cholesterol acyltransferase (LCAT) reactivity. Biochemistry. 44: 5409-5419.
81. Chroni, A., T. Liu, I. Gorshkova, H. Y. Kan, Y. Uehara, A. Von Eckardstein, and V. I. Zannis. 2003. The central helices of ApoAI can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type apoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. J. Biol. Chem. 278: 6719-6730.
82. Chroni, A., G. Koukos, A. Duka, and V. I. Zannis. 2007. The carboxyterminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo. Biochemistry. 46: 5697-5708.
83. Lins, L., S. Piron, K. Conrath, B. Vanloo, R. Brasseur, M. Rosseneu, J. Baert, and J. M. Rusysschaert. 1993. Enzymatic hydrolysis of reconstituted dimysteroylphosphatidylcholine-apo A-I complexes. Biochim. Biophys. Acta. 1151: 137-142.
84. Dalton, M. B., and J. B. Swaney. 1993. Structural and functional domains of apolipoprotein A-I within high density lipoproteins. J. Biol. Chem. 268: 19274-19283.
85. Ji, Y., and A. Jonas. 1995. Properties of an N-terminal proteolytic fragment of apolipoprotein A-I in solution and in reconstituted high density lipoproteins. J. Biol. Chem. 270: 11290-11297.
86. Calabresi, L., G. Tedeschi, C. Treu, S. Ronchi, D. Galbiati, S. Airoldi, C. R. Sirtori, Y. Marcel, and G. Franceschini. 2001. Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL. J. Lipid Res. 42: 935-942.
87. Roberts, L. M., M. J. Ray, T. W. Shih, E. Hayden, M. M. Reader, and C. G. Brouillette. 1997. Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I. Biochemistry. 36: 7615-7624.
88. Brock, J. W., A. J. Jenkins, T. J. Lyons, R. L. Klein, E. Yim, M. LopesVirella, R. E. Carter, S. R. Thorpe, and J. W. Baynes. 2008. Increased methionine sulfoxide content of apoA-I in type 1 diabetes. J. Lipid Res. 49: 847-855.
89. Shih, A. Y., P. L. Freddolino, A. Arkhipov, and K. Schulten. 2007. Assembly of lipoprotein particles revealed by coarse-grained molecular dynamics simulations. J. Struct. Biol. 157: 579-592.
90. Shih, A. Y., A. Arkhipov, P. L. Freddolino, and K. Schulten. 2006. Coarse grained protein-lipid model with application to lipoprotein particles. J. Phys. Chem. B. 110: 3674-3684.
91. Catte, A., J. C. Patterson, D. Bashtovyy, M. K. Jones, F. Gu, L. Li, A. Rampioni, D. Sengupta, T. Vuorela, P. Niemela, et al. 2008. Structure of spheroidal HDL particles revealed by combined atomistic and coarse-grained simulations. Biophys. J. 94: 2306-2319.
92. Catte, A., J. C. Patterson, M. K. Jones, W. G. Jerome, D. Bashtovyy, Z. Su, F. Gu, J. Chen, M. P. Aliste, S. C. Harvey, et al. 2006. Novel changes in discoidal high density lipoprotein morphology: a molecular dynamics study. Biophys. J. 90: 4345-4360.
93. Shih, A. Y., A. Arkhipov, P. L. Freddolino, S. G. Sligar, and K. Schulten. 2007. Assembly of lipids and proteins into lipoprotein particles. J. Phys. Chem. B. 111: 11095-11104.
94. Peters-Libeu, C. A., Y. Newhouse, S. C. Hall, H. E. Witkowska, and K. H. Weisgraber. 2007. Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution. J. Lipid Res. 48: 1035-1044.
95. Hristova, K., W. C. Wimley, V. K. Mishra, G. M. Anantharamiah, J. P. Segrest, and S. H. White. 1999. An amphipathic alpha-helix at a membrane interface: a structural study using a novel X-ray diffraction method. J. Mol. Biol. 290: 99-117.
96. Jonas, A., J. H. Wald, K. L. Toohill, E. S. Krul, and K. E. Kezdy. 1990. Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 265: 22123-22129.